Related Experiment Video
Updated: Jan 7, 2026
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Development and validation of machine learning models to predict PTSD at multiple time points in hospitalized trauma
Xiangyuan Chu1, Xiu Dai1, Xuheng Jiang2
1Department of Epidemiology and Health Statistics, School of Public Health, Zunyi Medical University, Zunyi, Guizhou, PR China.
Background:
Posttraumatic stress disorder (PTSD) is a severe trauma-related mental disorder with high global burden. Early identification remains challenging, particularly in developing regions. Leveraging routinely collected clinical biomarkers may offer a scalable solution for timely risk detection.
Method:
This multicenter study utilized two independent prospective trauma cohorts to develop and externally validate machine learning models for predicting PTSD at 1, 3, and 6 months post-trauma. The development cohort consecutively enrolled 382 hospitalized trauma patients (Nov 2023-Dec 2024), while the external validation cohort included 204 patients (Oct 2021-Nov 2022). Predictors comprised psychosocial variables and routine clinical biochemical markers, including inflammatory indicators, liver and renal function markers, and hematological parameters. Five models were constructed (Logistic Regression, Random Forest, SVM, XGBoost, and Neural Network), with performance evaluated by AUC and feature importance interpreted via SHAP.
Results:
Support Vector Machine achieved the best performance at 1 month (AUC = 0.84), while Random Forest models performed best at 3 and 6 months (AUC = 0.78 and 0.87). SHAP analysis indicated that ASDS were the most important predictors at all time points, with feature importance shifting over time. Acute stress and psychological state were dominant at 1 month, fearful experiences with physiological responses at 3 months, and chronic psychological burden and emotional state at 6 months.
Conclusions:
PTSD can be reliably predicted using psychosocial data and routine clinical biochemical markers. These findings support the integration of clinically accessible biological data into early PTSD risk screening, particularly in resource-limited settings.
